Evidence map›Paper›PMID 39854403›Full record

ArticlePloS one2025

Study protocol for a hybrid implementation-effectiveness trial of Game Changers for Cervical Cancer Prevention in Uganda.

Glenn J Wagner, Laura M Bogart, Joseph K B Matovu, Violet Gwokyalya, Jolly Beyeza-Kashesya, Allison Ober, Harold D Green, Sylvia Nakami, Margrethe Juncker, Eve Namisango and 4 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06010160 (A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06010160 nacompletednot on this map

A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda

TypeinterventionalSponsorRANDRan2024 to 2026Enrolled936ConditionsCervical CancerArmsGame Changers for Cervical Cancer Prevention
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Glenn J WagnerRAND Corporation, Santa Monica, California, United States of America.ORCID 0000-0001-9081-3299
Laura M BogartRAND Corporation, Santa Monica, California, United States of America.ORCID 0000-0003-3182-5542
Joseph K B MatovuSchool of Public Health, Makerere University, Kampala, Uganda.ORCID 0000-0001-6480-2940
Violet GwokyalyaSchool of Public Health, Makerere University, Kampala, Uganda.
Jolly Beyeza-KashesyaMulago Specialized Women and Neonatal Hospital, Kampala, Uganda.
Allison OberRAND Corporation, Santa Monica, California, United States of America.
Harold D GreenIndiana University School of Public Health, Bloomington, Indiana, United States of America.
Sylvia NakamiRays of Hope Hospice Jinja, Jinja, Uganda.
Margrethe JunckerRays of Hope Hospice Jinja, Jinja, Uganda.
Eve NamisangoAfrican Palliative Care Association, Kampala, Uganda.
Emmanuel LuyirikaAfrican Palliative Care Association, Kampala, Uganda.
Ryan K McBainRAND Corporation, Santa Monica, California, United States of America.
Kathryn BouskillRAND Corporation, Santa Monica, California, United States of America.
Rhoda K WanyenzeSchool of Public Health, Makerere University, Kampala, Uganda.

Funding

A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in UgandaR01CA282284 · NCI · RAND CORPORATION · PI Laura M Bogart, GLENN John WAGNER · 2023 to 2026
$2.8M
NCI NIH HHS R01 CA282284
6 · The paper itself

Abstract

introductionCervical cancer (CC) is the leading cause of cancer-related deaths among Uganda women, yet rates of CC screening are very low. Training women who have recently screened to engage in advocacy for screening among women in their social network is a network-based strategy for promoting information dissemination and CC screening uptake.

methodsDrawing on the Exploration, Preparation, Implementation and Sustainment (EPIS) framework for implementation science, this hybrid type 1 randomized controlled trial (RCT) of a peer-led, group advocacy training intervention, Game Changers for Cervical Cancer Prevention (GC-CCP), will examine efficacy for increasing CC screening uptake as well as how it can be implemented and sustained in diverse clinic settings. In the Preparation phase we will prepare the four study clinics for implementation of GC-CCP and the expected increase in demand for CC screening, by using qualitative methods (stakeholder interviews and client focus groups) to identify and address structural barriers to easy access to CC screening. In the Implementation phase, GC-CCP will be implemented over 36 months at each clinic, with screened women (index participants) enrolled as research participants receiving the intervention in the first 6 months as part of a parallel group RCT overseen by the research study team to evaluate efficacy for CC screening uptake among their enrolled social network members. All research participants will be assessed at baseline and months 6 and 12. Intervention implementation and supervision will then be transitioned to clinic staff and offered as part of usual care in the subsequent 30 months as part of the Sustainability phase. Using the RE-AIM framework, we will evaluate engagement in GC-CCP and CC advocacy (reach), alter CC screening (effectiveness), adoption into clinic operations, implementation outcomes (acceptability, feasibility, fidelity, cost-effectiveness) and maintenance. DISCUSSION: This is one of the first studies to use a network-driven approach and empowerment of CC screened peers as change agents to increase CC screening. If shown to be an effective and sustainable implementation strategy for promoting CC screening, this peer advocacy model could be applied to other preventative health behaviors and disease contexts.

trial registrationNIH Clinical Trial Registry NCT06010160 (clinicaltrials.gov; date: 8/17/2023).

Indexed as

Early Detection of CancerUterine Cervical NeoplasmsAdultFemaleHumansMass ScreeningRandomized Controlled Trials as TopicUganda

Identifiers

PMID39854403
PMCPMC11760014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.